首页> 外文期刊>Natural medicines =: 生薬学雜誌 >Screening of promising chemotherapeutic candidates against human adult T-cell leukemia/lymphoma from plants: active principles from Physalis pruinosa and structure-activity relationships with withanolides
【24h】

Screening of promising chemotherapeutic candidates against human adult T-cell leukemia/lymphoma from plants: active principles from Physalis pruinosa and structure-activity relationships with withanolides

机译:从植物中筛选有前景的针对成人T细胞白血病/淋巴瘤的化学疗法候选药物:酸浆的有效成分以及与withanolides的构效关系

获取原文
获取原文并翻译 | 示例
           

摘要

Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell malignancy caused by human T-cell lymphotropic virus type I (HTLV-1). Clinical manifestations of ATL range from smoldering to chronic, lymphoma and acute subtypes. Patients with acute and lymphoma-type ATL require therapeutic intervention. Conventional chemotherapeutic regimens used against other malignant lymphoma have been administered to ATL patients, but the therapeutic outcomes of acute and lymphoma-type ATL remain very poor. In this study, 214 extracts from 162 plants belonging to 65 families were screened for the purpose of elucidating the anti-proliferative effect against HTLV-1-infected T-cell lines. Extracts from aerial parts of Physalis pruinosa showed potent inhibitory effect. We isolated five withanolides from the extracts by activity-guided fractionation and examined the structure-activity relationships. The presence of a 5beta,6beta-epoxy function is suggested to be essential for the activity, and the most active principle showed selective toxicity to HTLV-1 -infected T-cell lines.
机译:成人T细胞白血病/淋巴瘤(ATL)是由人I型T细胞淋巴病毒(HTLV-1)引起的外周T细胞恶性肿瘤。 ATL的临床表现从阴燃到慢性,淋巴瘤和急性亚型。患有急性和淋巴瘤型ATL的患者需要治疗干预。已经针对ATL患者采用了用于治疗其他恶性淋巴瘤的常规化疗方案,但是急性和淋巴瘤型ATL的治疗效果仍然很差。在这项研究中,筛选了来自65个科的162种植物的214种提取物,以阐明其对HTLV-1感染的T细胞系的抗增殖作用。酸浆空地的提取物显示出有效的抑制作用。我们通过活性引导分级分离法从提取物中分离出五种山梨醇,并研究了结构-活性关系。提示5beta,6beta-环氧功能的存在对于该活性是必不可少的,并且最活跃的原理显示出对HTLV-1感染的T细胞系的选择性毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号